CACNG4

Chr 17

calcium voltage-gated channel auxiliary subunit gamma 4

CACNG4 encodes a transmembrane AMPA receptor regulatory protein (TARP) that regulates trafficking and gating of AMPA-selective glutamate receptors and modulates L-type calcium channel activity. The gene shows low constraint against loss-of-function variants (LOEUF 0.825), suggesting tolerance to such mutations. No established disease associations are currently documented for CACNG4 mutations.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 0.82
Clinical SummaryCACNG4
Population Constraint (gnomAD)
Low constraint (pLI 0.02) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
11 unique Pathogenic / Likely Pathogenic· 43 VUS of 57 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.82LOEUF
pLI 0.017
Z-score 2.01
OE 0.39 (0.200.82)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.82Z-score
OE missense 0.65 (0.560.75)
138 obs / 212.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.39 (0.200.82)
00.351.4
Missense OE0.65 (0.560.75)
00.61.4
Synonymous OE1.01
01.21.6
LoF obs/exp: 5 / 12.7Missense obs/exp: 138 / 212.9Syn Z: -0.11
DN
0.80top 10%
GOF
0.76top 25%
LOF
0.3068th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

57 submitted variants in ClinVar

Classification Summary

Pathogenic10
Likely Pathogenic1
VUS43
10
Pathogenic
1
Likely Pathogenic
43
VUS

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
10
0
10
Likely Pathogenic
0
0
1
0
1
VUS
0
42
1
0
43
Likely Benign
0
0
0
0
0
Benign
0
0
0
0
0
Total04212054

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CACNG4 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC